Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH

CompletedOBSERVATIONAL
Enrollment

389

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions
Malignant Tumor
Interventions
OTHER

Fibrin Structure

Modifications of Fibrin Structure in patients who have developed VTE in comparison with patients without VTE.

Trial Locations (1)

92701

Internal Medecine Department - Adults Pole and Hematology Laboratory Hôpital Louis Mourier (AP-HP), Colombes

Sponsors
All Listed Sponsors
collaborator

Hôpital Louis Mourier

OTHER

collaborator

Hopital Lariboisière

OTHER

lead

Diagnostica Stago R&D

INDUSTRY

NCT02552381 - Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH | Biotech Hunter | Biotech Hunter